797
Views
39
CrossRef citations to date
0
Altmetric
Cardiovascular

Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study

, , , , , , , , , , , , , , , , , , , , , , & show all
Pages 1491-1500 | Received 23 Mar 2018, Accepted 09 Apr 2018, Published online: 03 May 2018

References

  • Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012;379:815-22
  • Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med 2016;165:473
  • Bruck K, Stel VS, Gambaro G, et al. CKD prevalence varies across the European general population. J Am Soc Nephrol 2016;27:2135-47
  • Wang S, Chen R, Liu Q, et al. Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: the China Health and Retirement Longitudinal Study. Nephrol Carlton Vic 2015;20:474-84
  • Guo K, Zhang L, Zhao F, et al. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: cross-sectional study. J Diabetes Complications 2016;30:803-10
  • Schlieper G, Schurgers L, Brandenburg V, et al. Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 2016;31:31-9
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009;76 (Suppl. 113):S1-130
  • Hakeem A, Bhatti S, Chang SM. Screening and risk stratification of coronary artery disease in end-stage renal disease. JACC Cardiovasc Imaging 2014;7:715-28
  • Chen J, Budoff MJ, Reilly MP, et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol 2017;2:635-43
  • Karohl C, D’Marco Gascón L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol 2011;7:567-77
  • Collins AJ, Foley RN, Gilbertson DT, et al. United States renal data system public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl 2015;5:2-7
  • Hruska KA, Choi ET, Memon I, et al. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr Nephrol Berl Ger 2010;25:769-78
  • Wang M, Li H, You L, et al. Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients. PLoS One 2014;9:e93360
  • Shang D, Xie Q, Ge X, et al. Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients. BMC Nephrol 2015;16:107
  • Liu Z-H, China Dialysis Calcification Study (CDCS) group. Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study. BMC Nephrol 2015;16:129
  • Adragao T, Pires A, Branco P, et al. Ankle–brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 2012;27:318-25
  • O’Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol JASN 2001;12:2838-47
  • American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care 2011;34:S11-S61
  • European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-818
  • Mikolasevic I, Žutelija M, Mavrinac V, et al. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renov Dis 2017;10:35-45
  • Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32
  • Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997;132:245-50
  • on behalf of the C-STRIDE study group, Yuan J, Zou X-R, et al. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol [Internet]; 2017. Available at: http://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-017-0441-9. [Last accessed 17 January 2018]
  • Iimori S, Naito S, Noda Y, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study. Nephrol Carlton Vic 2015;20:601-8
  • Shah R, Matthews GJ, Shah RY, et al. Serum fractalkine (CX3CL1) and cardiovascular outcomes and diabetes: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis Off J Natl Kidney Found 2015;66:266-73
  • Ritchie J, Rainone F, Green D, et al. Extreme elevations in blood pressure and all-cause mortality in a referred CKD population: results from the CRISIS study. Int J Hypertens 2013;2013:597906
  • Martínez-Castelao A, Górriz JL, Portolés JM, et al. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol 2011;12:53
  • Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695-701
  • Liu W, Zhang Y, Yu C-M, et al. Current understanding of coronary artery calcification. J Geriatr Cardiol JGC 2015;12:668-75
  • Kraus MA, Kalra PA, Hunter J, et al. The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: a cross-sectional observational study. Ther Adv Chronic Dis 2015;6:84-96
  • Lumlertgul D, Kantachuvesiri S, Apichaiyingyurd S, et al. Prevalence of and predictive factor for abdominal aortic calcification in Thai chronic kidney disease patients. Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther 2017;21:611-19
  • Qunibi WY, Abouzahr F, Mizani MR, et al. Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. Kidney Int 2005;68:271-7
  • Wang AY-M, Ho SS-Y, Wang M, et al. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med 2005;165:327-32
  • Coen G, Pierantozzi A, Spizzichino D, et al. Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol 2010;11:10
  • Abdelmalek JA, Stark P, Walther CP, et al. Associations between coronary calcification on chest radiographs and mortality in hemodialysis patients. Am J Kidney Dis 2012;60:990-7
  • Kestenbaum BR, Adeney KL, de Boer IH, et al. Incidence and progression of coronary calcification in chronic kidney disease: the multi-ethnic study of atherosclerosis. Kidney Int 2009;76:991-8
  • Sigrist M, Bungay P, Taal MW, et al. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 2006;21:707-14
  • Rroji M, Seferi S, Cafka M, et al. Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients? Int Urol Nephrol 2014;46:175-82
  • Yao Q, Duddington M. Peritoneal dialysis in China. Perit Dial Int 2014;34:S29-30
  • Lumlertgul D, Kantachuvesiri S, Kriengsak V, et al. Corrected serum calcium as a predictive factor for abdominal aorta calcification in CKD patients on dialysis.Poster presented at the 53rd ERA-EDTA Congress, Vienna May 21st - 24th, 2016
  • Tatami Y, Yasuda Y, Suzuki S, et al. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease. Atherosclerosis 2015;243:349-55
  • Okuno S, Ishimura E, Kitatani K, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis Off J Natl Kidney Found 2007;49:417-25
  • Bellasi A, Block GA, Ferramosca E, et al. Integration of clinical and imaging data to predict death in hemodialysis patients. Hemodial Int Int Symp Home Hemodial 2013;17:12-18
  • Hong D, Wu S, Pu L, et al. Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study. BMC Nephrol 2013;14:120
  • Lee Y-T, Ng H-Y, Chiu TT-Y, et al. Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients. Clin Chim Acta Int J Clin Chem 2016;452:38-43
  • Kim J-K, Park S, Lee MJ, et al. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis 2012;220:208-14
  • Gorriz J, Molina P, Escudero V, et al. Vascular calcification in patients with chronic kidney disease stages 4 & 5. Poster presented at the 53rd ERA-EDTA Congress;Vienna May 21st - 24th, 2016
  • Chen X-N, Chen Z-J, Ma X-B, et al. Aortic artery and cardiac valve calcification are associated with mortality in Chinese hemodialysis patients: a 3.5 years fllow-up. Chin Med J (Engl) 2015;128:2764
  • Tison GH, Guo M, Blaha MJ, et al. Multisite extracoronary calcification indicates increased risk of coronary heart disease and all-cause mortality: the multi-ethnic study of atherosclerosis. J Cardiovasc Comput Tomogr 2015;9:406-14
  • Nasrallah MM, El-Shehaby AR, Salem MM, et al. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 2010;25:2679-85
  • Jean G, Bresson E, Terrat J-C, et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 2009;24:948-55
  • Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis Off J Natl Kidney Found 2008;52:519-30
  • Di Iorio B, Bellasi A, Russo D, et al. Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol CJASN 2012;7:487-93
  • KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2017;7:1-59
  • Goldsmith DJ, Covic A, Sambrook PA, et al. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 1997;77:37-43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.